Introduction to Xeljanz
Xeljanz is a medication that belongs to a class of drugs known as Janus kinase inhibitors. It is used to treat certain autoimmune conditions, such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. The active ingredient in Xeljanz is tofacitinib, which works by blocking the Janus kinase enzymes in the body that are involved in the inflammatory process.
Uses of Xeljanz
Xeljanz is prescribed to manage the symptoms of autoimmune diseases, including reducing joint pain, swelling, and inflammation in conditions like rheumatoid arthritis. It can also be used to treat moderate to severe ulcerative colitis in adults who have not responded well to other medications. In some cases, Xeljanz may be prescribed off-label for other conditions, as determined by a healthcare provider.
Dosage and Administration
The dosage of Xeljanz will be determined by your healthcare provider based on your medical condition and response to treatment. It is available in tablet form and is usually taken orally twice daily with or without food. Follow the prescribed dosing schedule and instructions provided by your doctor to ensure the medication's effectiveness.
Possible Side Effects
Like all medications, Xeljanz may cause side effects in some individuals. Common side effects include headache, diarrhea, and upper respiratory tract infections. Serious side effects such as increased risk of infections, liver damage, and blood clots may also occur in rare cases. Inform your doctor immediately if you experience any unusual or severe side effects while taking Xeljanz.
Precautions and Warnings
Before starting treatment with Xeljanz, inform your healthcare provider about any medical conditions, allergies, or medications you are currently taking. Xeljanz may interact with certain drugs or increase the risk of infections, so it is important to disclose all relevant information to your doctor. Avoid live vaccines while on Xeljanz treatment and consult your healthcare provider for guidance on vaccination schedules.